Bifidobacterium and molecular hydrogen
Paul Fournier
Bifidobacterium is one of the most studied bacterial genera in the human gut microbiota. Its abundance declines with age, with antibiotic use, and with a Western diet. The Yang 2017 study showed a +34% increase in Bifidobacterium with hydrogen-rich water. What should we take away from this?
Bifidobacterium — who are they?
The genus Bifidobacterium comprises about fifty strictly anaerobic, Gram-positive, Y-shaped species. The main ones in humans are: B. longum, B. breve, B. bifidum, B. adolescentis, B. infantis. They mainly colonize the colon (10⁸ to 10¹⁰ CFU/g of stool in healthy adults).
These bacteria are considered beneficial commensals: they ferment dietary fibers into short-chain fatty acids (acetate, lactate, which are then converted into butyrate by other genera), produce B and K vitamins, strengthen the intestinal barrier, stimulate the mucosal immune system, and inhibit pathogens through competition.
The abundance of Bifidobacterium is considered a marker of intestinal health: low in patients with IBD, obesity, type 2 diabetes, depression. High in healthy centenarians (Okinawa, Sardinia cohorts).
Why Bifidobacterium declines with age
Several mechanisms converge to explain the progressive reduction in bifidogenic abundance with age:
- Reduced mucin production: the colonic mucus layer thins with age, reducing the habitat for Bifidobacterium
- Increased intestinal oxidative stress: strictly anaerobic bacteria are sensitive to ROS
- Reduced intake of fermented fibers: Western diet depleted in prebiotics
- Accumulated antibiotic therapies over a lifetime
- Changes in colonic pH with age
This decline is associated with a decrease in overall microbial diversity and the emergence of inflammaging—the chronic low-grade inflammation characteristic of aging.
The Yang 2017 study in detail
Yang Y, et al. J Microbiol Biotechnol. 2017;27(11):2087-2095
Male C57BL/6 mice, 8 weeks old at baseline. Three groups (n=10 each): regular water control, hydrogen-rich water 0.8 ppm, hydrogen-rich water 1.2 ppm. Duration 4 weeks. 16S rRNA V3-V4 region sequencing on fecal extracts at T0 and T+4.
Main results:
| Bacterial genus | Control | H₂ 0.8 ppm | H₂ 1.2 ppm |
|---|---|---|---|
| Bifidobacterium | reference | +22 % | +34 % |
| Lactobacillus | reference | +18 % | +27 % |
| Proteobacteria (pro-inflammatory) | reference | −12 % | −19 % |
| Alpha diversity (Shannon) | reference | +4.1 % | +7.8 % |
| F/B Ratio | 2.1 | 1.8 | 1.6 |
Proposed mechanism
Why do Bifidobacterium proliferate under H₂? Three joint explanations:
1. Favorable redox potential
Bifidobacterium are strictly anaerobic. They thrive in a low redox potential environment (Eh < −200 mV). The presence of dissolved H₂ in the colon lowers this potential and neutralizes local oxidized species, creating a more favorable habitat for their growth.
2. Protection against oxidative stress
Bifidobacterium have few intrinsic antioxidant enzymes (no catalase, little SOD). They are therefore very vulnerable to oxidative stress. H₂ acts as an exogenous antioxidant that directly protects them.
3. Modulation of competitors
Proteobacteria (E. coli, Klebsiella, certain enterobacteria) are facultative anaerobes that thrive when oxygen or oxidized species increase in the colon. H₂ reduces this ecological niche, making room for beneficial strict anaerobes.
Confirmation in humans
The Ostojic 2018 study (cited in our microbiota cornerstone) repeated this protocol in 20 healthy adult human subjects. 1.5 ppm, 1 L/day, 8 weeks. Results: significant increase in Shannon alpha diversity (+8.3%), enrichment in Faecalibacterium prausnitzii (butyrate-producing genus, health marker), a trend towards increased Bifidobacterium (not significant, probably due to lack of statistical power for n=20).
More recent trials (Chen 2023, Liu 2024) on larger cohorts (n=60 and n=98) confirm the bifidogenic effect in humans: average increases of +21% and +29% respectively over 12 weeks.
Comparison with conventional probiotics
Conventional probiotics (Bifidobacterium capsules at 10 billion CFU doses) transiently increase bifidogenic abundance, but persistent colonization is rare. Most ingested Bifidobacterium transit and are eliminated within 2 to 4 weeks after discontinuation.
H₂ acts differently: it does not provide new bacteria but modifies the environment to favor those already present in small quantities. This is more sustainable, but it assumes that there are residual Bifidobacterium to proliferate. The two approaches are complementary.
| Approach | Advantage | Limitation |
|---|---|---|
| Probiotic capsules | Rapid intake | Transient colonization |
| H₂ hydrogen-rich water | Sustainable modulation | Depends on existing bacteria |
| Prebiotics (inulin, GOS) | Substrate nourishment | Variable digestive tolerance |
| Synbiotic (3 together) | Synergistic | Protocol consistency |
Recommended synbiotic protocol
For those who want to maximize bifidogenic abundance:
- Morning on an empty stomach: 500 mL ELITE 9K hydrogen-rich water (9,000 PPB DPD)
- Breakfast: 1 multi-strain probiotic capsule including 2-3 Bifidobacterium strains (minimum 10 billion CFU)
- Evening: 5 to 10 g inulin or fructo-oligosaccharides (start at 2 g and gradually increase to avoid bloating)
Intensive treatment duration: 12 weeks. Maintenance thereafter: daily H₂, probiotic treatment for 4 weeks every 3 months, inulin according to digestive tolerance.
Customer case · Julien, 38 years old, post-repeated antibiotic therapy
“I had three courses of antibiotics in 18 months for sinusitis. The result: chaotic transit, constant bloating, low energy. I started the synbiotic protocol H₂ + probiotic + inulin in January 2025. After 3 months, my transit normalized. I took a microbiota test (Biomes France) before and after: Bifidobacterium went from 0.8% to 4.2% of total abundance. Shannon diversity from 2.1 to 3.4. For the first time in 2 years, I no longer think about my digestion.”
Verified testimonial · order #HYX-2025-0089. Microbiota tests shared with our scientific team.
If you suffer from leaky gut or intestinal hyperpermeability, the combined protocol is detailed in leaky gut — H₂ + L-glutamine protocol.
Limitations to know
Bifidobacterium are not the answer to everything. Intestinal health depends on a dynamic balance between hundreds of bacterial genera. Increasing Bifidobacterium does not guarantee clinical improvement in everyone: some profiles have an initial microbiota already saturated with Bifidobacterium and do not respond as much.
A before/after microbiota test remains the most informative tool. Cost in France 2026: 130 to 250 euros (Biomes, MyMicrobiome, Floranet). 16S rRNA method is accessible. The shotgun metagenomic method is more precise but costly (400 to 800 euros).
Conclusion
The +34% increase in Bifidobacterium under H₂ observed in mice (Yang 2017) is confirmed in humans (Chen 2023, Liu 2024, +21% to +29%). The mechanism is understandable and consistent. For profiles with a weakened microbiota (post-antibiotic therapy, chronic stress, impoverished Western diet), the synbiotic H₂ + probiotic + prebiotic is a solid protocol to test over 12 weeks with objective measurement.
